在治疗儿科喘的精确护理
Lina Mahmood1, Sevdenur Keskin, Akilah A Jefferson
1Department of Pediatric Allergy and Immunology, University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock, Arkansas, USA.
Current opinion in pediatrics
|February 27, 2024
概括
针对儿科喘的精准医学使用像生物药物一样的向疗法,专注于特定的途径. 在识别生物标志物和遗传关联方面的进展提高了治疗疗效和患者的治疗结果.
科学领域:
- 儿科肺病学 儿科肺病学
- 免疫学 免疫学 免疫学
- 药物基因组学 药物基因组学
背景情况:
- 精准医学根据患者个体特征量身定制喘治疗方法.
- 了解基因和免疫路径是开发向治疗的关键.
研究的目的:
- 审查当前生物药物治疗儿科喘的疗效.
- 讨论最近在识别生物标志物和个性化喘护理的遗传关联方面的进展.
主要方法:
- 在小儿喘中精准医学方法的文献综述.
- 对当前生物疗法和新兴生物标志物的分析.
- 检查影响喘管理的遗传关联.
主要成果:
- 针对2型通路的生物药物,如dupilumab和mepolizumab,在恶化率和肺功能上显示出显著的改善.
- 像微分呼出氧化 (FeNO) 这样的生物标志物有助于对治疗反应进行分类.
- 基因组研究越来越多地为精密护理策略做出了贡献.
结论:
- 基于免疫学和遗传学理解的向治疗改善了儿科喘管理.
- 精准医学,结合生物标志物和遗传数据,为儿科喘护理提供了一个有希望的未来.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
Inhaled Medications
261
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
261
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
COPD: Management Using Bronchodilators and Corticosteroids
206
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
206
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
297
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
297


